These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38428823)

  • 1. The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.
    Pihlmann Kristensen M; Korsgaard U; Timm S; Hansen TF; Zlobec I; Hager H; Kjær-Frifeldt S
    Hum Pathol; 2024 Apr; 146():15-22. PubMed ID: 38428823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Multicenter Study on the Prognostic and Predictive Impact of Tumor Budding in Stage II Colon Cancer: Results From the SACURA Trial.
    Ueno H; Ishiguro M; Nakatani E; Ishikawa T; Uetake H; Matsuda C; Nakamoto Y; Kotake M; Kurachi K; Egawa T; Yasumasa K; Murata K; Ikawa O; Shinji S; Murotani K; Matsui S; Teramukai S; Tomita N; Sugihara K;
    J Clin Oncol; 2019 Aug; 37(22):1886-1894. PubMed ID: 31180819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathological Predictors of Recurrence in Stage III Colon Cancer: Reappraisal of Tumor Deposits and Tumor Budding Using AJCC8 Criteria.
    Landau MA; Zhu B; Akwuole FN; Pai RK
    Int J Surg Pathol; 2019 Apr; 27(2):147-158. PubMed ID: 29992847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
    Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
    Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer.
    Lee VWK; Chan KF
    Pathol Res Pract; 2018 Mar; 214(3):402-407. PubMed ID: 29487008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
    Betge J; Kornprat P; Pollheimer MJ; Lindtner RA; Schlemmer A; Rehak P; Vieth M; Langner C
    Ann Surg Oncol; 2012 Nov; 19(12):3706-12. PubMed ID: 22669453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer.
    Saito K; Okuyama T; Miyazaki S; Oi H; Mitsui T; Noro T; Takeshita E; Ono Y; Urahashi T; Tajima H; Yoshitomi H
    In Vivo; 2022; 36(4):1820-1828. PubMed ID: 35738585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
    Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
    Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical significance of tumor budding detection in stage II colon cancer].
    Liu SJ; Yang XH; Ren JQ; Zhu XJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Aug; 16(8):730-4. PubMed ID: 23980042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of tumor budding in stage II colon cancer: exploring zero budding as a prognostic marker.
    Pihlmann Kristensen M; Korsgaard U; Timm S; Frøstrup Hansen T; Zlobec I; Kjær-Frifeldt S; Hager H
    Virchows Arch; 2024 Oct; 485(4):691-701. PubMed ID: 38977466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA mismatch repair status and colon cancer recurrence and survival in clinical trials of 5-fluorouracil-based adjuvant therapy.
    Sinicrope FA; Foster NR; Thibodeau SN; Marsoni S; Monges G; Labianca R; Kim GP; Yothers G; Allegra C; Moore MJ; Gallinger S; Sargent DJ
    J Natl Cancer Inst; 2011 Jun; 103(11):863-75. PubMed ID: 21597022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is High-Grade Tumor Budding an Independent Prognostic Factor in Stage II Colon Cancer?
    Kyong Shin J; Ah Park Y; Wook Huh J; Hyeon Yun S; Cheol Kim H; Yong Lee W; Hyung Kim S; Yun Ha S; Cho YB
    Dis Colon Rectum; 2023 Aug; 66(8):e801-e808. PubMed ID: 35394982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
    Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
    BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effect of tumor budding on the benefit of adjuvant chemotherapy in stage II colorectal cancer: a retrospective observational study.
    Ran X; Chen Y; Liu C; Xiao H; Su X; Chen Z; Du J; He J; Zhong P; Li M; Dai N; Chen C
    J Gastrointest Oncol; 2024 Aug; 15(4):1545-1555. PubMed ID: 39279933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphovascular invasion, perineural invasion, and tumor budding are prognostic factors for stage I colon cancer recurrence.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
    Int J Colorectal Dis; 2020 May; 35(5):881-885. PubMed ID: 32112198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexistence of MACC1 and NM23-H1 dysregulation and tumor budding promise early prognostic evidence for recurrence risk of early-stage colon cancer.
    Ozturk E; Aksoy SA; Ugras N; Tunca B; Ceylan S; Tezcan G; Yilmazlar T; Yerci O; Egeli U; Cecener G
    APMIS; 2018 Feb; 126(2):99-108. PubMed ID: 29700912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.
    Kim JE; Hong YS; Kim HJ; Kim KP; Lee JL; Park SJ; Lim SB; Park IJ; Kim CW; Yoon YS; Yu CS; Kim JC; Hoon KJ; Kim TW
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S630-7. PubMed ID: 26271397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
    Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
    Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surveillance for early stages of colon cancer: potentials for optimizing follow-up protocols.
    Gilardoni E; Bernasconi DP; Poli S; Garancini M; Luperto M; Zucchini N; Bovo G; Totis M; Bugatti A; Gianotti L
    World J Surg Oncol; 2015 Aug; 13():260. PubMed ID: 26311420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.